1276P Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): Real-world 3-year outcomes within overall and special populations (the UNIVOC study)
J-B. Assié, R. Corre, Matteo Giaj Levra et al. · Annals of Oncology · 2020
Cited by 1 works. doi:10.1016/j.annonc.2020.08.1590 Open-access PDF
Authors
- J-B. Assié
- R. Corre
- Matteo Giaj Levra
- Christophe Yannick Calvet
- V. Grumberg
- A.F. Gaudin
- Baptiste Jouaneton
- FE Cotté
- CHRISTOS CHOUAID